PillRx only · Tablet, Film Coated, Extended Release · Oral
Naproxen Sodium
Brands: Naprelan · Naproxen Sodium
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US15 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$9.593
Latest avg · Jul 22, 2026
+18%
Since Dec 17, 2025
4
Active US suppliers
82%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
2.0K
Rx · 2026 Q1
133K
Units dispensed
+12%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 2 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Upsher-Smith Laboratories, LLC | unknown | 6 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 3 | SUPPLYING |
| SPIRIT PHARMACEUTICALS LLC | unknown | 1 | SUPPLYING |
| SA3, LLC | unknown | 1 | SUPPLYING |
| Alvogen Inc. | unknown | 2 | EXITED 2027 |
| Almatica Pharma LLC | unknown | 2 | EXITED 2027 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.